Parliament Question: Pharmaceutical & Medical Devices Promotion and Development Scheme

GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS LOK SABHA UNSTARRED QUESTION No. 3652 TO BE ANSWERED ON THE 13TH MARCH 2026 Pharmaceutical & Medical Devices Promotion and Development Scheme 3652. Shri Daggumalla Prasada Rao: Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state: (a) the total number of beneficiaries under the Pharmaceutical & Medical Devices Promotion and Development Scheme (PMPDS) during the last five years, State/district-wise and year-wise including Andhra Pradesh; (b) the total amount sanctioned and disbursed under PMPDS, State-wise and year-wise; (c) the number of seminars, conferences, workshops, conventions and exhibitions supported with financial assistance under PMPDS during the last three years, State-wise and year-wise; (d) the details of mega events organized including India Pharma and India Medical Device meets, their frequency, locations, participating States, total expenditure incurred and outcomes achieved; and (e) the number of organizations that have received logo support from the Department for their events, State-wise and the criteria followed for granting such non-financial support? ANSWER THE MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS (SMT. ANUPRIYA PATEL) (a) to (d): Pharmaceutical and Medical Devices Promotion and Development Scheme (PMPDS) aims to facilitate growth and development of pharmaceutical sector through study/survey reports, awareness programs, creation of databases and promotion of industry. Since FY2021-22, Department has conducted 25 studies and evaluations on topics of importance to the Department and has organized/supported 65 events/workshops/seminars/webinars across the country to sensitize the pharmaceutical and medical devices industry on various topics through academic institutions, government autonomous bodies, firms empanelled with Government of India, National/State level industry associations, non-profit companies/organization in pharmaceutical & medical devices sector, private companies of good repute and Government agencies. Seminars/workshops conducted under the scheme are organised at various locations across the country including Andhra Pradesh and are open to participants from the pharmaceutical and medical sectors nationwide. The total amount sanctioned and disbursed under PMPDS year-wise is given at Annexure-I. The number of seminars, conferences, workshops, conventions and exhibitionssupported with financial assistance under PMPDS during the last three years is given at Annexure-II. The details of mega events organised under PMPDS including India Pharma and India Medical Device meets, locations, participation from different states, total expenditure incurred including Grant-in-Aid under the PMPDS and outcomes achieved are at Annexure-III. (e): Department of Pharmaceuticals have supported 20 events with non-financial logo support under PMPDS since 2021-22. The non-financial logo support is provided to various organizations for Pharma and Medical Device events in compliance with the scheme guidelines.Annexure I Annexure referred to in reply to part (a) to (d) of the Lok Sabha Unstarred Question No. 3652 for answer on 13.3.2026, raised by Shri Daggumalla Prasada Rao, regarding Pharmaceutical and Medical Devices Promotion and Development Scheme Details of amount sanctioned and disbursed for preparing various study reports and organizing various seminars, conferences, conventions, workshop and exhibitions under PMPDS during last five years. S. Item 2021-22 2022-23 2023-24 2024-25 2025-26 No. (as on 12.3.2026) 1. Amount sanctioned (₹ in 2.00 3.00 7.00 4.00 4.83 lakh) for studies and events 2. Amount Disbursed (₹ in 1.20 0.81 2.77 2.02 1.80 lakh) for studies and eventsAnnexure II Annexure referred to in reply to part (a) to (d) of the Lok Sabha Unstarred Question No. 3652 for answer on 13.3.2026, raised by Shri Daggumalla Prasada Rao, regarding Pharmaceutical and Medical Devices Promotion and Development Scheme Details of number of seminars, conferences, workshops, conventions and exhibitions supported with financial assistance under PMPDS during the last three years S. No. Item 2022-23 2023-24 2024-25 1. No. of seminars, conferences, workshops, 3 11 14 conventions and exhibitions supported with financial assistanceAnnexure III Annexure referred to in reply to part (a) to (d) of the Lok Sabha Unstarred Question No. 3652 for answer on 13.3.2026, raised by Shri Daggumalla Prasada Rao, regarding Pharmaceutical and Medical Devices Promotion and Development Scheme Details of mega events organised under PMPDS including India Pharma and India Medical Device meets, their locations, participating states, total expenditure incurred including Grant-in- Aid under the PMPDS and outcomes achieved. S. Name Date of Location(s) Participating Total Key Outcomes No of event States Expendit Achieved Mega ure Event incurred (₹ in lakh) 1. India 25.2.20 FICCI, Maharashtra, 18.52 The India Pharma & India Pharma 21 to Federation Karnataka, Medical Devices 2021 and 26.2.20 House, New Gujarat, Conference advanced India 21 Delhi Rajasthan, dialogue between Medical and Delhi, Haryana, government and industry Device 1.3.202 Madhya on policy priorities and 2021 1 to Pradesh, Orissa, sectoral reforms. Key (Hybrid 2.3.202 Goa, Uttar outcomes included Mode) 1 Pradesh, emphasis on Telangana, strengthening domestic Chhattisgarh, manufacturing, Kerala, enhancing resilient Himachal supply chains, promoting Pradesh, innovation and R&D, Uttarakhand, improving healthcare Punjab and access, and supporting Andhra Pradesh digital health and through Andhra advanced medical Pradesh technologies to position MedTech Zone India as a global hub for (AMTZ) affordable medicines and medical device manufacturing.S. Name Date of Location(s) Participating Total Key Outcomes No of event States Expendit Achieved Mega ure Event incurred (₹ in lakh) 2. India 25.4.20 Dr. Maharashtra, 85.80 The India Pharma 2022 Pharma 22 to Ambedkar Karnataka, and India Medical and 27.4.20 International Gujarat, Device 2022 India 22 Centre, New Rajasthan, Conferences led to key Medical Delhi Delhi, Haryana, outcomes including Device Madhya strengthened dialogue 2022 Pradesh, Orissa, between government and Goa, Uttar industry on policy Pradesh, support and ease of doing Telangana, business, promotion of Chhattisgarh, domestic manufacturing Kerala, and resilient supply Himachal chains, and greater focus Pradesh, on innovation, digital Uttarakhand, health, and advanced Punjab and medical technologies. Andhra Pradesh The deliberations also through Andhra emphasized regulatory Pradesh collaboration, value- MedTech Zone based healthcare, and (AMTZ) enhanced investments through industrial clusters and medical device parks to position India as a global hub for pharmaceuticals and medical devices. 3. India 26.5.20 Hotel Ashok, 113.73 The 8th Edition of India Pharma 23 to New Delhi Pharma & India and 27.5.20 Medical Devices 2023 India 23 strengthened Medical collaboration among Device government, regulators, 2023 industry, and academia to advance domestic manufacturing, innovation, and global competitiveness. Key outcomes included emphasis on scaling MedTech innovations to large-scale manufacturing,S. Name Date of Location(s) Participating Total Key Outcomes No of event States Expendit Achieved Mega ure Event incurred (₹ in lakh) strengthening quality and R&D capabilities, promoting digital transformation and biosimilars in pharmaceuticals, and fostering industry– academia partnerships to support sustainable growth of India’s healthcare ecosystem. 4. India 17.8.20 Gandhinagar 815.10 The India MedTech Medtec 23 to , Gujarat Expo 2023 showcased h Expo 19.8.20 India’s growing 2023 23 capabilities in the medical devices sector and strengthened engagement among policymakers, industry, start-ups, academia, and international stakeholders. Key outcomes included promotion of indigenous innovations and start-ups, facilitation of global business partnerships through buyer–seller meetings, identification of investment opportunities, and enhanced collaboration in R&D, skill development, and advanced healthcare technologies, reinforcing India’s position as an emerging hub for medical device manufacturing and innovation. *****